Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe

PURPOSE: Erythropoiesis-stimulating agents can reduce red blood cell transfusion rates in patients developing anemia while receiving chemotherapy. We investigated potential cost savings from reduced transfusion rates in patients starting darbepoetin alfa (DA) at higher versus lower hemoglobin (Hb) l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Deger, Melike, Eisterer, Wolfgang, Kutikova, Lucie, Salek, Sam
Format: Artigo
Idioma:Inglês
Publicat: Springer-Verlag 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3538022/
https://ncbi.nlm.nih.gov/pubmed/22825456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-012-1538-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars